Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 6,000 shares at $33.22 ($195K) on 2015-07-20, disclosed to the SEC on 2015-07-21.
Scheduled sale ($195k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.29 | 3,900 | $126K | 64.7% |
| 2 | $32.31 | 1,000 | $32K | 16.6% |
| 3 | $32.74 | 100 | $3K | 1.7% |
| 4 | $33.22 | 200 | $7K | 3.4% |
| 5 | $33.22 | 800 | $27K | 13.6% |
| Total | $32.46 avg | 6,000 |
| $195K |
| 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |